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ABSTRACT 
Recently, the use of acellular matrices in tissue engineering has become extremely significant as 
tissue substitute for organ/tissue reconstruction. In this clinical scenario, banking decellularised 
organs ready for transplantation would be mandatory for patients with emergency needs. 
In this work a new process based on supercritical carbon dioxide (SC-CO2) drying technique was 
investigated for obtaining a dry/preserved decellularized oesophagus. Experiments were performed 
coupling a detergent enzymatic treatment with two different protocols: (i) SC-CO2 drying; (ii) 
dehydration in ethanol and a subsequent SC-CO2 drying. The efficiency of the treatments was 
investigated by monitoring the loss of weight of the treated samples and the maintenance of the 
extracellular matrix (ECM) architecture, composition and mechanical properties after rehydration. 
A successful dry acellular matrix was reached in a shorter time using the combined ethanol and SC-
CO2 treatment. Histological analysis reported the maintenance of the tissue matrix architecture and 
the collagen content for all the treated samples, while the preservation of ultrastructural features 
were confirmed by scanning electron microscopy (SEM). Tensile tests did not show significant 
differences in terms of fracture strength before and after the supercritical process. Furthermore, the 
scaffolds demonstrated good biocompatible properties in terms of cell culture viability in vitro. 
Overall, the results highlighted the potential of this novel technology to obtain a dried acellular 
matrix for oesophageal regeneration, preserving the extracellular matrix structure of the native 
tissue. 
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INTRODUCTION 
Surgical oesophagus replacement may occur in many congenital [1] and acquired diseases [2]. 
Nowadays, the most commonly applied clinical treatment for oesophagus replacement is the 
substitution using the stomach (gastric pull-up), the colon (colonic interposition) or the small bowel, 
with high risks associated with morbidity and potential post-surgical complications [3-7]. 
Oesophageal tissue engineering (OTE) is an emerging alternative for the development of suitable 
tissue replacements for oesophageal repair. In the last decay, oesophageal engineered substitutes 
have been explored using several synthetic and natural derived scaffolds and materials [8]. Early 
studies seem to indicate that using synthetic material, such as silicone-based scaffolds lead to poor 
result in animal models [9, 10], while naturally derived collagen scaffolds showed promising results 
[11, 12].  
Indeed, starting from the native tissue has already shown some value for clinical translation, and 
organ decellularization for tissue engineering has become more and more promising for the 
organ/tissue replacement with initial satisfactory clinical experience with simpler tabularised organs 
[37,38]. Organs that are more complex have also been engineered using decellularized materials in 
experimental animals such as heart [39] liver [13], kidney [14], intestine [40] and other 
organs/tissues [15-17]. Our group has recently demonstrated that a natural oesophageal acellular 
matrix can be also obtained directly from pig oesophagus, maintaining the ultrastructure and 
composition of the native extracellular matrix (ECM) [18]. These scaffolds could represent a valid 
therapeutic solution for the replacement of damaged organ, overcoming rejection and 
immunosuppression complication. Typically, natural acellular matrices from animal tissues are 
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obtained through different chemical and enzymatic treatments [15-18]. Despite the safety of the 
procedure, detergent residua might be presented at the end of the process causing high toxicity and 
therefore limiting their use at clinical level [19]. Moreover, most of those processes are conducted 
with freshly isolated tissue that is promptly transplanted after the decellularisation/recellularization 
process. However, this limits the potential use in the clinical scenario where an ad hoc preparation 
may not always be possible, and banking decellularised organs ready for transplantation may offer 
advantage for patients with emergency needs. To date limited knowledge is available about the 
storage and preservation of these decellularized tissues. Regarding the preservation of the 
decellularized trachea, there is evidence that the maintenance of the decellularized scaffold is 
limited to few weeks after their production, requiring storage solutions and controlled temperatures 
[20]. Nowadays no efficient and inexpensive protocol is available for long-term maintenance of 
natural decellularized scaffolds. It is known that sterilization processes can significantly affect both 
the structure and the residual protein content [21] thus, there is a need for new conservation 
methods.  
The drying process has a great potential as preserving option and it has already been largely used 
for the food products [22]. It is widely known that the residual water, or in other terms the water 
activity, is mostly in charge of microbial development and quality decay, while its removal ensures 
long term conservation. 
A recent drying technique for long-term preservation in the food processing has been proposed by 
Brown et al. [23]. They applied SC-CO2 and EtOH+SC-CO2 drying treatment to carrots, 
demonstrating that samples displayed more favourable rehydrated textural properties than air-dried 
equivalents, with no substantial change of product microstructure. 
 In the same way, SC-CO2 drying treatment could allow long-life to natural acellular scaffolds, 
acting like a storage treatment and avoiding their rapid degradation.  
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Advancements in the production and long-term preservation technology of a natural acellular matrix 
could be achieved by using supercritical carbon dioxide (SC-CO2) drying process which has been 
already investigated for food [23] with promising applications as maintenance process. SC-CO2 has 
already shown interesting application for biomaterials on the preparation of 3D porous scaffolds  
and hydrogel [24-28]. Carbon dioxide (CO2) has a moderate critical point (31°C, 7.38 MPa), that 
makes it suitable for the studies where thermal degradation must be avoided. Additionally, SC-CO2 
displays bactericidal properties, making it an attractive solvent for applications where sterilization 
steps are required [29-31].  
In this work, we specifically investigated the effect of SC-CO2 drying for the development of a dry 
natural-based engineered tissue that can be used as alternative for oesophageal substitution. To the 
best of our knowledge, this is the first time that SC-CO2 drying technique has been applied to a 
natural acellular matrix obtained via DET.  
We used SC-CO2 drying technique on a decellularized scaffold obtained from porcine oesophagus 
and evaluated the morphological, mechanical and structural changing induced by the treatment. 
Two different experimental procedures have been explored: a single step SC-CO2 drying at 35°C 
and 10 MPa for 60 or 120 min, and a combined double step with ethanol (EtOH) for 80 min 
followed by SC-CO2 drying (EtOH+SC-CO2) at 35°C and 10 MPa for 15 or 30 min. The weight 
was measured for both dried and rehydrated samples, followed by analysis for the evaluation of 
macro and micro structure, mechanical properties and ECM components. Additionally, we proved 
the capability of cell adhesion and viability performing a set of preliminary repopulation 
experiments with human bone marrow mesenchymal stem cells (hBM-MSCs) up to 7 days of 
culture in customized microwell. 
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MATERIALS AND METHODS 
2.1 Organ harvest 
Pigs were euthanized by administration of an overdose of intravenous Pentobarbital Sodium 
(Sigma). Oesophagi were harvested from white domestic piglets (n=4), aged from 12 to 16 weeks 
and weighted from 25 to 40 kg. Following a midline incision, the oesophagus was harvested and 
washed with a phosphate buffer solution (PBS, Life Technology, pH 7.4) containing 5% antibiotic 
antimycotic solution (PBS/AA). All surgical procedures and animal handling were carried out in 
accordance with UK Home Office guidelines under the Animals (Scientific Procedures) Act 1986 
and the local ethics committee. 
2.2 Acellular matrix generation 
Oesophageal decellularization was achieved by using a detergent enzymatic treatment (DET) 
following the procedure of Totonelli et al. [18]. Briefly, the oesophageal lumen was perfused by 
three subsequent cycles of DET using a variable speed roller pump (Masterflex L/S, Cole Palmer) at 
0,6 ml/min. During each cycle, samples were immersed in 3 subsequent solutions: deionised water 
(resistivity 18.2 MΩ/CM) at 4°C for 24 h, 4% sodium deoxycholate (Sigma Aldrich) at room 
temperature for 4 h, and 50 Kunitz units DNase-I (Sigma Aldrich) in 1 M NaCl solution (Sigma 
Aldrich) at room temperature for 3 h. Planar samples (d=8mm and h=7mm) from 110 to 150 mg 
weight were obtained by dissecting the oesophagus between the upper and lower sphincters on the 
longitudinal axis, using a 8 mm diameter biopsy punch (B life). Rectangular samples were obtained 
for the mechanical tests (see Mechanical Test section for further detail). The decellularized samples 
were processed and used within 2 months from the DET. 
2.3 Supercritical drying  
The supercritical drying process (SC-CO2) took place in a high pressure sapphire visualization cell 
(Separex S.A.S., France) with an internal volume of 50 ml, designed to resist up to 40 MPa and 
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100°C. A thermostatic bath and an HPLC pump (Gilson 25SC; Gilson S.A.S, France) allowed to set 
the internal temperature and pressure, respectively. Liquid CO2 (Messer, carbon dioxide 4.0, purity 
99.990%) was fed into the reactor by the pump with a flow rate of about 25 ml/min until reaching 
10 MPa of pressure. SC-CO2 drying treatments were performed at 35°C and 10 MPa: samples were 
treated for 60 or 120 min when only SC-CO2 was applied, while 15 or 30 min in case the samples 
were firstly dehydrated with a graded EtOH solution. The dehydration was performed dipping the 
samples in graded EtOH series solutions (50%, 75%, 95%, and 99.8%) for 20 min at each step. To 
ensure the water and ethanol content removal, an on-off valve and a micrometric valve were 
concurrently used to maintain the pressure at a constant level and obtain a semi-continuous flow. 
Furthermore, these valves allowed the depressurization of the system in a range of 1 min to 60 min 
at the end of the process. To avoid any microbial contamination during the opening and sampling 
operation, a Bunsen burner flame was placed near the reactor chamber and the treated samples were 
collected with sterile tweezers in sterile tubes. The vessel was cleaned and disinfected with EtOH 
(96% v/v, Sigma Aldrich) after each sampling. Supplementary Fig.1 shows a picture of the 
experimental set up for the SC-CO2 drying.  
2.4 Sample weight analysis 
Samples weights were measured before and after each treatment using a microbalance (OHAUS® 
Explorer, Nänikon, CH). It was assumed that all weight loss was due to the humidity removal. The 
weight reduction was expressed as the ratio of % Wend/Wstart where Wend and Wstart were 
respectively the weight of the sample before and after the treatment. As control, we also carried out 
a vacuum drying process for the untreated and treated samples. The vacuum drying system 
consisted of a vacuum chamber, a mechanical vacuum pump and a condensate trap (cooled in liquid 
nitrogen) that were used to remove and trap the humidity. Reduction of the pressure to 10-4 MPa 
allowed the liquid to evaporate at room temperature, while a nitrogen flow into the vacuum 
chamber allowed the samples to be dried in the absence of humid air for the entire time of the 
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treatment. Statistical significance was evaluated with a post hoc ANOVA and Bonferroni 
correction. 
Rehydration efficiency was calculated as weight recover. Dry samples were rehydrated in milliQ 
water at room temperature. All the mechanical and structural tests were performed on rehydrated 
samples placed overnight in milliQ water. All the additional investigations on the scaffold property 
were evaluated using 120 min drying for the SC-CO2 treatment, while in the combined treatment 
EtOH+CO2 the timing was 80 min and 15 min respectively for each step. 
2.5 SEM analysis and Porosity calculation 
Samples were fixed in 2.5% v/v glutaraldehyde in 0.1 M phosphate buffer and left for 24 h at 4 °C. 
Following washing with 0.1 M phosphate buffer, samples were cut into segments of approximately 
0.5 cm length and cryoprotected in 25% sucrose, 10% glycerol in 0.05 M PBS (pH 7.4) for 2 h, then 
fast frozen in nitrogen slush and fractured. Samples were then placed back into the cryoprotectant at 
room temperature and allowed to thaw. After washing in 0.1 M phosphate buffer (pH 7.4), the 
material was fixed in 1 % OsO4/0.1 M phosphate buffer (pH 7.3) at 3°C for 1.5 h and washed again 
in 0.1 M phosphate buffer (pH 7.4). After rinsing with water, specimens were dehydrated in a 
graded ethanol-water series to 100 % ethanol, critical point dried using CO2 and finally mounted on 
aluminum stubs using sticky carbon taps. The fractured material was mounted to present fractured 
surfaces across the parenchyma to the beam and coated with a thin layer of Au/Pd (approximately 
2 nm thick) using a Gatan ion beam coater. Images were recorded with a 7401 FEG scanning 
electron microscope (Jeol, USA) at several magnifications. 
Porosity was calculated using ImageJ software as percentage of poruses area. A minimum of 5 
random 400x images per area (muscularis externa and submucosa) were collected and analyzed 
from 3 different samples.  
2.6 Mechanical characterization 
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Tensile tests were performed using a Midi 10 electromechanical testing machine by MESSPHYSIK 
Material Testing. Samples were cut with regular rectangular shape (about 12 x 9 mm2) and fixed to 
the loading frame through double adhesive tape at both ends (Supplementary Fig. 4). Tests were 
performed at a speed of 1 mm/s, corresponding to a strain rate of 0.06 s-1-0.12 s-1 for isolated 
muscle samples and composite samples consisting of both epithelium and muscle. Tests have been 
performed with either longitudinal or transversal orientation for each sample’s typology. Load per 
unit width was recorded as a function of strain. This choice was a consequence of the significant 
variability in the samples thickness, which on turn affected reliability of the stress calculation. In 
fact, along with the same sample, thickness could vary by even more than 50%. All the tests were 
performed at room temperature at least in duplicate. Treated sample were subjected to EtOH (80 
min)+SC-CO2 (10MPa, 35°C) followed by an overnight rehydration in milliQ water. 
2.7 Histological analysis 
The samples were frozen in 2-methyl-butane (Sigma Aldrich) cooled in liquid nitrogen, and 9-µm-
thick sections were prepared onto Superfrost slides (Thermo Scientific, Rockville, MD, USA) using 
a cryomicrotome (Cryostat Leica 1860, Leica biosystem, MI, Italy). Tissue slides were fixed with 
2% paraformaldeihyde in PBS for 10 min and stained with Haematoxylin and Eosin (H&E) 
(BioOptica, MI, Italy), Masson’s trichrome (MT) (BioOptica, MI, Italy) and Alcian blue (AB) 
(BioOptica, MI, Italy) stains. Images were obtained using a microscope (Leica DMR, Leica 
microsystem, MI, Italy) equipped with the Leica Application software (LAS). 
2.8 Cell culture and scaffold repopulation  
Human bone marrow mesenchymal stem cells (hBM-MSCs) were provided by the Cell factory of 
Policlinico di Milano. hBM-MSCs were expanded in tissue culture T75 flask with complete 
medium: Mem-alpha (Life Technology, 32661), 10% Fetal Bovine Serum (FBS, Life 
Technologies), 1% Penicillin-Streptomycin (Life Technologies). Before reaching the confluence, 
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cells were trypsinized with Trypsin-EDTA 0.25% (Life Technologies) and seeded into either 
conventional well or above the decellularized scaffold.  
The dry decellularized samples, not stored in dried form for long-term, were previously rehydrated 
overnight in milliQ water and then washed in Mem-alpha before an overnight conditioning at 37°C 
in an incubator with 300μL of Mem-alpha for each sample. Medium was collected in order to 
evaluate the presence of toxic residuals. Each sample was inserted inside a customized microwell 
(Supplementary Fig 3 and Fig 4 for more technical details) made of 2 layers of 
Polydimethylsiloxane (PDMS, Dow Corning) in the ratio 1:10 (base: cure agent). A 24 well was 
used to place the microwell. Cells were seeded at 100k/μwell in 150μL of completed medium for 
each microwell above the muscle layers placed in the up side of the microwell. Cells were left to 
adhere overnight before adding 1 mL of completed medium for each well. Medium was changed 
every 2 days up to 7 days of culture. Live and dead analysis (Life technology) were performed to 
evaluate the viability at the surface. At the end of the culture, samples were fixed with 
paraformaldehyde (PFA, Sigm-Aldrich), 4% in PBS 1X (Life Technologies) for 30 min and then 
frozen as reported in the Histological analysis section.  
Medium collected after matrix conditioning was used to culture 30kcells/well hBM-MSCs in 48 
well. Morphological changing was checked daily and live and dead analysis were also performed. 
2.9 Immunofluorescence analysis  
Human protein marker was verified by immunofluorescence analysis for SUN1 while cell 
proliferation for ki-67. Briefly, samples slices were fixed with 2% PFA (Sigma-Aldrich) for 10 min, 
permeabilized with 0.5% Triton X-100 (Sigma-Aldrich) and blocked in 2% horse serum (Life 
Technologies) for 45 min at room temperature. The rabbit monoclonal primary antibody against 
SUN1 (Sigma-Aldrich) was applied overnight at room temperature, followed by incubation with the 
Alexa594 fluorescence-conjugated anti-rabbit IgG secondary antibody (Life Technologies) for 1 
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hour at 37 °C. Nuclei were counterstained with Hoechst (Life Technologies) while cytoplasm was 
marked by incubation 1 h at 37°C with Phalloidin (Life Technologies). The mouse monoclonal 
primary antibody against Ki-67 (Sigma-Aldrich) was applied for 1 h at 37°C, followed by 
incubation with the Alexa594 fluorescence-conjugated anti-mouse IgG secondary antibody (Life 
Technologies) for 1 hour at 37 °C. Nuclei were counterstained with Hoechst (Life Technologies). 
After staining, slices were mounted in HI-MO (Lab-Optica) and analysed with the inverted 
microscope LeicaDMI6000B equipped with a mercury short-arc reflector lamp (Leica, Germany) or 
Leica TCS SP5 confocal microscope. 
RESULTS 
3.1 Generation of a dry acellular matrix 
Dry acellular matrices were produced using two different methods, SC-CO2 alone and a combined 
double step of ethanol (EtOH) followed by SC-CO2 drying (EtOH+SC-CO2) as shown in Table 1. 
For drying with pure CO2 (T1 and T2), a significant effect of the treatment time on the drying 
efficiency, in terms of weight reduction, was evident causing about 63% weight reduction in 60 min 
and about 90% weight reduction in 120 min, respectively (Figure 1A). When dried first with EtOH 
for 80 min (T3 and T4), a significant reduction in weight of about 90% compared to SC-CO2 alone 
was observed after only 15 min of treatment (Figure 1B). This result could be easily explained as a 
pre-treatment of EtOH for 80 min was able to produce alone a weight reduction of about 55%. No 
significant weight reduction was noticed when the SC-CO2 treatment was prolonged to 30 min of 
treatment. The EtOH pre-treating time was selected at 80 min based on the reduction of sample 
weight as function of the residence time (Supplementary Fig. 3). Residence times higher than 80 
min did not shown significant differences in water replacement. When samples were left overnight 
in EtOH solution (data not shown), a further weight loss of about 33% was observed; however this 
treatment time was not taken into account as a significant shrinkage of the samples occurred. 
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An extensive vacuum process was applied to assess the residual water/liquid content in the samples 
after the drying processes. Both samples treated with SC-CO2 and EtOH+ SC-CO2, showed from 0.5 
to 1 % mass reduction after 12 h vacuum treatment, while  the control, composed of a decellularized 
but not dried sample,  resulted in a 90.5 % weight reduction after 12 h of the single vacuum step, 
confirming that the complete moisture drying was basically achieved with both treatments. The 
rehydration capacity of the dried samples was studied in order to investigate the possibility to 
restore the moisture content after the drying process. As showed in Figure 1C and 1D, all the treated 
samples reported no differences in the total amount of moisture uptake, which ranged from about 
65±3.5 to 72.2±1.1 % of the starting weight after 1 h. Representative pictures of the samples before 
and after the drying process and rehydration are shown in Supplementary Figure 2. The combined 
EtOH+SC-CO2 (80 min + 15 min) drying ensured a greater retention of the original volume and 
shape compared to the drying with SC-CO2 (120 min). Despite this observation, no differences in 
weight reduction and rehydration recovery between the two different drying treatments were 
observed. 
3.2 Evaluation of Structural and Mechanical properties 
H&E, MT and AB staining (Figure 2 A, B) were performed to evaluate the maintenance of ECM 
architecture before and after the SC-CO2 and the EtOH+SC-CO2 treatments compared with a 
decellularized control sample that were not dried. H&E staining confirmed the absence of intact 
nuclei after DET and highlighted the generation of micro-porosity after SC-CO
2
 treatment (Figure 
2A). The generation of micro-porosity after the SC-CO2 and the EtOH+SC-CO2 treatments occurred 
in absence of any visible histological damage to the EMC structure. The preservation of the 
oesophageal architecture was demonstrated with the presence of the three layers: mucosa, 
submucosa and muscular layers (Figure 2B) in all the analyzed samples. Masson’s Trichrome 
staining pointed out the maintenance of the collagen in the lamina propria, submucosa and 
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intermuscular septa of the muscularis externa. AB staining did not show a further decrease of 
glycosaminoglycan (GAG) after the SC-CO2 and the EtOH+SC-CO2 treatments.  
The porosity of the samples was investigated through SEM analysis as a function of different 
depressurization times at the end of the drying processes (Fig 3). The porosity increased 
significantly only for the EtOH +SC-CO2 treatment (Fig 3C) for both muscular and submucosa 
layers and the highest increase was shown for the submucosa. The depressurization time did not 
affect the porosity of the samples measured after the treatments. 
The mechanical properties in terms of strength and maximum strain did not show significant 
differences as reported in Fig. 4. Generally, the treated samples showed a bigger strain at fracture 
for both longitudinal and transversal samples compared to the fresh ones. For the composite 
samples (muscle + epithelium, Fig 4B) a bigger ultimate load/width was also observed for both 
transversal and longitudinal samples. However, although similar samples extracted from the same 
tissue and with the same orientation were taken into account, the biological nature of the tested 
samples affected the repeatability of the mechanical measurements, showing in some cases up to 
100% and 80% difference in maximum load/width and elongation, respectively (data not shown).  
3.3 Scaffold biocompatibility and cell repopulation 
Biocompatibility was investigated through toxicity test evaluating alive and dead cells on the 
surface of samples and via conditioned medium. We demonstrated that harmful substances were 
absent after the SC-CO2 treatment. In supplementary Fig 8 can be appreciated the toxic behaviour 
only with the conditioned medium with the untreated sample. Live and dead test showed higher 
mortality for the untreated samples compared to the treated ones after 48 hours (Supplementary Fig 
8E) and the presence of few cells in culture after 5 days (Supplementary Fig 8F) for the same set of 
samples. These data were also validated from live and dead test on the sample surface (data from 
untreated sample not shown). High cell density and low mortality after 7 days of culture for the 
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samples treated with the EtOH+SC-CO2 method is evident (Fig 5A and the enlargement Fig 5B-D). 
Analogous results are reported in Supplementary Fig 9 for the SC-CO2 treatment although 
variability was observed for samples derived from different animals (data not shown). Histological 
analysis demonstrated the presence of cells only on the surface of the samples (Fig 5E-F). The 
human cells were detected with specific human antibody for SUN1 as reported in Supplementary 
Fig 8 excluding the presence of residual nuclei from the decellularization process. Moreover, an 
efficient cell surface proliferation at 7 days was revealed by Ki67 staining as shown in 
Supplementary Fig 10. 
DISCUSSION 
Decellularized scaffolds, based on animal or human organs, are highly attractive in order to develop 
natural substitution for transplantation. In this study, we obtained a dry acellular oesophagus matrix 
by applying SC-CO2 drying process to a decellularized oesophagus prepared by DET. We 
demonstrated that no significant additional reductions in weight could be reached after the 
achievement of about 90.5% of the native weight. After SC-CO2 treatment, the amount of residual 
water in the moisture was comparable to the amount reached after 12 h of extensive vacuum 
treatment. A dry ECM was successfully generated in a short time using EtOH+SC-CO2 treatment 
(90% weight reduction after 15 min), while SC-CO2 alone induced the same weight reduction but 
with longer times, 120 min. Faster processes are preferred not only for an industrial need (more 
sample treated in less time, less amount of reagents), but also because the contact time among the 
sample and chemicals is shorter and, likely, alteration of structural and composition might be 
reduced. The addition of EtOH as co-solvent during the process favourably influenced the solubility 
of polar solvent in SC-CO2, including water [32, 33].  
The process conditions (10 MPa and 35°C) used in this study were optimized on the base of 
previous researches. We have shown that above 10 MPa CO2 solubility is a weak function of 
pressure [34, 35]. We also [35] demonstrated that a pressure increase from 10 to 30 MPa did not 
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influence significantly CO2 solubility in the water contained in samples [36]. Temperature was 
fixed at 35°C to exploit CO2 properties in supercritical phase. Experiments at higher temperatures 
were not taken into account based on CO2 solubility, which decreases as temperature increases [34]. 
Moreover, higher temperatures could damage the protein content and also irreversibly degrade the 
sample.  
Rehydration has to be considered as an indicator of the structural restoration after drying, as it 
influences both mechanical and morphological properties. In our study we did not observed 
substantially differences between the rehydration time and the weight recovery between the two 
processes. Moreover, the drying and rehydration steps did not influence the ECM organization; 
H&E staining revealed the preservation of a multi-layered macro-architecture. In addition, MT and 
AB staining showed collagen maintenance and no apparent GAG reductions after the SC-CO2 and 
the EtOH+SC-CO2 treatments. This is an important result since Totonelli et al. previously revealed 
a significant GAG decreasing associated to the loss of the glandular structure after the DET 
treatment [18]. 
The SC-CO2 and EtOH+ SC-CO2 treatment generated diffused micro-porosity with no visible 
histological damage to the ECM structure layers. The load/width-strain curves did not show 
significant changes before and after the treatment in case of both longitudinal and transversal 
sections. The porosity was higher for the EtOH+ SC-CO2 treatment as expected; indeed the co-
solvent influence positively the SC-CO2 solubility. On venting the SC-CO2 by depressurization, a 
supersaturation of CO2 is generated and hence nucleation and growth occurred into the matrix. No 
significant difference between depressurization time was found, probably because of the low 
solubilisation of SC-CO2 in the polymeric matrix.  
To ensure the maintenance of the cell adhesion protein and the absence of chemical residuals from 
the previous DET, we performed a set of proof of concept cell culture repopulation experiments 
using the rehydrated matrix. hBM-MSCs were viable and proliferating at the surface after 7 days of 
culture for both the treatments. Since SC-CO2 is largely used as extracting component, we had 
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evidence that SC-CO2 could be used also to eliminate toxic chemical residual from the 
decellularization process. We supposed that an extensive removal of chemicals from DET could not 
be guaranteed only by the use of traditional washing method due to the thickness and low porosity 
of the oesophagus samples. We showed that cell cultured through the conditioned media from the 
untreated samples were less viable compared to those from treated samples. These preliminary 
experiments on viability are very important for the development of artificial organs for 
transplantation. Human BM-MSCs are a good model for a preliminary study of cell viability 
because of their capability to differenziate in several different cell type, in particular myocytes and 
fibroblast. Moreover BM-MSCs are one of the most promising cell source for cell therapy and are 
largely used in many trials. 
SC-CO2 showed attractive properties in the development of a dry scaffold with no substantial 
alteration of structural, mechanical and biological properties after rehydration. Both treatments here 
presented allowed to obtain dry matrices but the EtOH+SC-CO2 method allows a faster drying with 
a higher porosity rate. Additional studies are needed in order to investigate the possibility to extract 
other volatile component other than water with both the treatment. The generation of controlled 
pores in size and number could be a useful property for further cell scaffold re-seeding prior 
implantation. However, further studies are needed in order to confirm the advantages of porosity in 
the ECM for cell scaffold repopulation. Specific studies are also required in order to increase the 
cell repopulation inside the acellular matrix. The use of a specific co-culture in vitro model or 
chemo-attractive component could give substantial advantages for cell repopulation. Moreover, the 
effect of SC-CO2 sterilization on the microbial content of the natural derived tissue is also important 
to be explored in the perspective of a standard clinical grade scaffold. Supplementary studies are 
needed and they require aged dried samples in order to control the maintenance of biological and 
mechanical properties. 
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CONCLUSION 
Taking advantage of SC-CO2 drying process, we obtained a dry decellularized scaffold that could be 
used for the development of organ/tissue substitution. A dry acellular matrix was obtained coupling 
SC-CO2 drying technique to a decellularized oesophagus obtained via DET. The treatment allowed 
the obtainment of a dry scaffold with preserved both its macro and micro structure, which also 
showed good biocompatible properties in terms of cell culture viability in vitro. The results of the 
present study clearly demonstrated that SC-CO2 treatment represents a promising innovative 
technique for the preparation of novel organ/tissue substitution a-toxic, in absolute dry conditions 
and with a suitable structure for cell repopulation. This study, which focused for the first time on 
oesophagus decellularized scaffold, could provide a novel approach to derive a standard technique 
for the preservation of other natural-derived scaffolds. 
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Table 1. Summary of the experimental conditions applied at at 35°C and 10 MPa. 
Treatment Conditions 
T1 60 min SC-CO2 
T2 120 min SC-CO2 
T3 80 min EtOH + 15 min SC-CO2 
T4 80 min EtOH + 30 min SC-CO2 
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Figure 1. (A) Loss of weight percentage of ECM after SC-CO2 treatments (T1 for 60 min and T2 for 
120 min), SC-CO2 treatment for 120 min + vacuum drying for 12 h (T2+vacuum), and vacuum 
drying for 12 h as control (vacuum); (B) Loss of weight percentage of ECM after EtOH dehydration 
(80 min), EtOH dehydration (80 min) and SC-CO2 treatments (T3 for 15 min and T4 for 30 min), 
EtOH dehydration (80 min) + SC-CO2 for 30 min + vacuum drying for 12 h (T4+ vacuum), and 
vacuum drying for 12h as control (vacuum); (C) Rehydration kinetics of dried samples after SC-
CO2 treatment (♦, 60 min (T1); ►, 120 min (T2)); (D) and EtOH (80 min)+ SC-CO2 treatment (●, 
15 min (T3); ■, 30 min (T4)). 
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Figure 2. Histological analysis. A). H&E staining confirmed the absence of intact nuclei and the 
generation of a micro-porosity after SC-CO
2
 treatment (120 min) and EtOH (80 min)+ SC-CO2 
treatment (15 min) (B). H&E staining demonstrated the maintenance of oesophageal architecture 
with the presence of mucosa, submucosa and muscular layers. MT staining confirmed the 
preservation of collagen in the intermuscular septa of muscularis externa, submucosa and lamina 
propria. AB staining did not show GAG loss (c). Scale bars 100 µm for 200 X, 250 µm for 100 X, 
500 µm for 50 X.  
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Figure 3. Porosity analysis. (A) SEM images representing the thickness of a decellularized and not 
dried  sample (control) divided in Muscularis External (ME) and Submucosa Sub. (B) Percentages 
of porosity for different treatments and depressurization time (1 min, 2 min 60 min) for Muscularis 
Externa and Submucosa (average of 3 samples and >5 measurements), (C) SEM images for 
different treatment and depressurization times.  
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Figure 4: Load/width-strain curves derived for transversal (black) and longitudinal (red) samples 
consisting of muscle (A) and of both epithelium and muscle (B) extracted from either treated 
(dotted line) or control tissue (solid line) referred to a not dried decellularized tissue. 
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Figure 5: Cell Repopulation. Live and dead analysis of the sample surface after 7 days of culture 
with BM-MSc (A) merged pictures of calcein and red enlargement in green Calcein (B), Nuclei in 
blue with Hoechst (C) and Ethidium in red (D). Images of Slices in Phase (E) and with merged 
nuclei (blue) and phalloidin (green). Sample after treatment with EtOH and SC-CO2. 
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Supplementary Fig. 1 
 
Experimental SC-CO2 set up. Image of the sapphire reactor (A) with two detailed views of the 
chamber (length (F) and diameter (G)),control pressure measurement (B), thermostatic liquid inlet 
in the external shell of the reactor (C), (D) Temperature measurement and controller, (E) CO2 
pump; the red arrows show the CO2 inlet/outlet in the reactor. (H) sequential images showing the 
small steel baskets used for sample placement inside the reactor. 
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Supplementary Fig. 2 
 
Sample preparation. Decellularized pig oesophagus before (A) and after (B) opening. (C) Planar 
sample (D= 8mm) obtained after cutting. (D) Visual comparison between sample before and after 
SC-CO2 treatment and rehydration for the combined and single treatment.  
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Supplementary Fig. 3 
 
Dehydration with Ethanol. Reduction of sample’s weight as a function of the residence time in 
EtOH solution. 
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Supplementary Fig. 4 
 
Tensile Test. (A) Picture of the sample fixed to the loading frame before applying the strain. 
(B),(C),(D) sequence of images during the test. 
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Supplementary Fig. 5 
 
Microwell design and Fabrication. (A) Upper view and (B) lateral section S1 with quotes of the 
microwell. The PDMS was previously prepared with a 10:1 base to cure agent ratio and cured for at 
least 2 hours at 80°C inside a petri dish followed by cutting with scalpels. The microwell is 
composed of 2 PDMS layers bonded together via plasma treatment (C). Then, the 2 layers were 
bounded to a circular 12mm glass slice (menzel Glaser) via UV ozone (D). (E) reports a picture of 
the final microwell. Before using, the microwell was sterilized via autoclave.  
  
36 
 
Supplementary Fig. 6 
 
Sample insertion into microwell and cell culture. Schematic sequence of matrix insertion inside 
the microwell before cell seeding. (A) Sample was placed on the top of the microwell and using a 
sterile tweezers (C) put inside the well (B and D). Then the microwell was moved inside a 24 well 
(E) where cells were seeded (F) suspended in 150 μL of medium. After O/N incubation additional 1 
mL of medium was added in each well, covering the entire surface of the microwell (G).  
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Supplementary Fig. 7 
 
Toxicity. Phase images after 48 hours of hBM-MSCs with fresh media (CTRL) (A) and with 
conditioned media for sample treated with combined Ethanol and SC-CO2 treatment (B), 120 
minute SC-CO2 (C) or no treated sample (D). (E) Live and dead analysis expressed as number of 
dead cells versus total cells at 48 hours for the same previous conditions. (F) Cells/mm2 after 5 days 
of culture for the same conditions. 
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Supplementary Fig. 8 
 
 
Immunofluorescence analysis: SUN1. Phase and fluorescence images for hBM-MSCs (CTRL +) 
on well, and slices of fresh porcine esophagus before decellularization (CTRL-) and decelularized 
and repopulated samples. Images at 40X for CTRL+ and 10X for the others. SUN1 is marked in 
red, while nuclei in blue. 
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Supplementary Fig. 9 
 
Cell repopulation at 7 days for sample treated with SC-CO2. Live and dead analysis of the 
sample surface after 7 days of culture with hBM-MSCs (A) merged pictures of calcein and red 
enlargement in green Calcein (B), Nuclei in blue with Hoechst (C) and Ethidium in red (D). Images 
of Slices in Phase (E) and with merged nuclei (blue) and phalloidin (green).  
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Supplementary Fig. 10 
 
Immunofluorescence analysis: Ki67. Fluorescence images for hBM-MSCs after 7 days of culture 
with Hoechst (blue), Phalloidin (green) and Ki67 antibody (red). Merge image with Hoechst and 
Ki-67. 
 
 
